Profit booking causes dip in equity indices after rally. IDBI Bank, Suzlon Energy, RIL, HDFC Bank, Kotak Mahindra Bank, and JSW Steel in fo...

Several widely followed companies, including Jio Financial, Paytm, Bajaj Auto, Asian Paints, LTIMindtree, Infosys, Reliance Industries, Wip...

Angel One's fourth-quarter profit rose 27% as trading activity helped more than make up for its higher spending amid heated competition for...

Nearly 130 companies, including Tata Motors and Indigo, will be announcing their December quarter earnings. Tata Motors is expected to have...

YES Bank on Saturday reported robust growth in profit for the December quarter, with the bottomline surging more than four times year-on-ye...

On Monday, Torrent Pharmaceuticals, Lloyds Metals & Energy, PNB Housing Finance, Alok Industries, Mahindra Holidays & Resorts India, Kewal ...

Private banking giants HDFC Bank, Kotak Mahindra Bank, YES Bank, and ICICI Bank are scheduled to release their earnings for the first quart...

Jubilant Pharmova's quarterly net loss widened to INR 98 crore in the March quarter of FY23 from a loss of INR 15.67 crore in the previous ...

Jubilant Pharmova has posted a net loss of Rs 98 crore in the fourth quarter ended March. Revenue from operations during the quarter stood ...

Nifty stocks fell short of the estimated 10.6% with 9.7% while Nifty 500's earnings improved by 11.7% compared to the estimated 8.9%, indic...

The texture of the chart formation and technical indicators such as RSI is indicating at a likely reversal from the current levels, which c...

Other than quarterly results, Garware Technical shall consider the buyback of shares. Vodafone Idea’s board will meet for a preferential sh...

A few analysts believe revenues have bottomed out for drug maker Jubilant Pharmova, others do not hold high hopes in the short term

Newly-listed startups such as Zomato, Nykaa and Policybazaar are among the 10 stocks that are likely to find a place in the Association of ...

Consolidated total revenue from operations stood at Rs 1,657.45 crore in the second quarter as against Rs 1,591.35 crore in the year-ago pe...

Revenue from continuing operations stood at Rs 1,634.65 crore in the quarter under review. It was Rs 1,156.07 crore in the same period a ye...

Jubilant Pharma has successfully completed "safety and pharmacokinetic/absorption studies in animals and healthy human volunteers in India ...